Clinical Trials Directory

Trials / Sponsors / Kala Pharmaceuticals, Inc.

Kala Pharmaceuticals, Inc.

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
CompletedSafety and Efficacy of KPI-121 in Subjects With DED
Kerato Conjunctivitis Sicca
Phase 32018-07-10
TerminatedKPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children
Ocular Inflammation
Phase 32018-07-03
CompletedSafety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Dry Eye Syndromes, Keratoconjunctivitis Sicca
Phase 32016-06-01
CompletedSafety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain
Post Surgical Ocular Inflammation and Pain
Phase 32016-06-01
CompletedSafety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Dry Eye Syndromes, Keratoconjunctivitis Sicca
Phase 32016-06-01
CompletedExploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macul
Retinal Vein Occlusion, Diabetic Macular Edema
N/A2014-07-01
CompletedSafety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
Blepharitis
Phase 22014-07-01
CompletedSafety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Dry Eye Syndromes, Keratoconjunctivitis Sicca
Phase 22014-06-01
CompletedSafety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation
Ocular Infections, Irritations and Inflammations
Phase 32014-05-01